An Iranian-French scientist recently announced that he has planned an investment in a bankrupted French pharmaceutical company.  The biggest investor in this undertaking, which was not revealed in this announcement, is Iran’s government.

According to the Wall Street Journal, this move signifies one of the most recent attempts by Iran’s regime to use foreign investments to fight against the sanctions. 

This investment’s advisor has revealed that the complete amount of investment is 5 million dollars, which comes from investment accounts and cash resources of 22 countries.

The report calls this an act in good faith to save Iran’s regime from Isolation and to generate some revenue.

Iran’s weak economy has been hit hard since President Trump’s decision to leave JCPOA and reestablish the sanctions in order to force the regime to stop its military interventions in the region and to reduce the size of Iran’s ballistic missiles program.

While a new round of sanctions will go into effect on November 4th, the foreign investment of Iran’s regime is one of the ways that allows them to bypass the sanctions. Other measures that the regime is taking, are trying to create a barter system where it can receive goods in exchange for oil, and to replace the European companies that are leaving the country with Asian companies.